Advancing Drugs

 Call for expert advice  202-780-4988

   Developing a Drug?   Leverage our Experience.


Contact us for quotations or initial advise

                          

              Preclinical strategy


Without a well thought out preclinical IND strategy, you run the risk of spending more money and incurring more time executing the necessary requirements of the FDA.   


We start by learning about your molecule and current formulation, building a program that starts from where your last assay & testing left off. Contact us for a gap analysis and initial advisory based on your situation.



Contact Us!


Got Questions?

We have Answers


We are experienced drug development professionals.   We offer preclinical services and key insight necessary to take your drug development program to IND submission.  DMPK, formulation, GLP toxicology, API synthesis and free initial consulting.  Contact us for a free GAP ANALYSIS assessment today.

Advancing Drugs has brought over 30 drugs through IND submission.  We can augment your knowledge and capabilities in any area of the drug development process.


We provide Individual preclinical CRO services or Fully Integrated preclinical service programs:

  • GLP toxicology & safety pharmacology studies (preclinical toxicology)
  • Preclinical advisory - initial designs and advisory at no charge
  • Small molecule synthesis and Biologics development (through our partner CMO)
  • Formulation for small molecules & Biologics (insoluble compounds, covalently bonded, etc.)
  • Project Management and Filings
  • eCTD compilation & filings



Drug Candidate Selected?


We provide everything you need to get your drug substance into clinic Trials



We work with you to get your drug into the clinic


Our experience will help you anticipate problems before they occur

Expert Team


The Advancing Drugs provides preclinical CRO services and has a highly experience staff of drug development experts specializing in the all areas of preclinical service required for FDA IND (Investigation New Drug) submission. Collectively, this expertise covers the drug development continuum from DMPK to candidate nomination to IND submission.

Experience Includes:

  • Preclinical CRO Services
  • Over 30 Preclinical INDs filed
  • 25+ years of experience
  • Regulatory filings


Learn More

About Us